Medical research communities warned that the administration of popular antidepressants during early trimester of pregnancy can increase the risk of neonatal heart defects by two folds.
According to Dr. Stephen Pilling, Professor, National Institute for Health and Care Excellence (NICE), the research evidences reported that the risk is imminent with maternal administration of Selective serotonin reuptake inhibitor (SSRI).
Several research evidences and other efforts are being put forth by the clinicians to put off smoking habits and alcohol consumption during pregnancy. However, no such efforts are being taken with antidepressant drugs, which may increase, manifold risk of heart defects in the neonates, Dr. Stephen noted.
Dr. Stephen informed that maternal guidance should be issued by the gynecologists to gestational women about the potential risk of heart defects in neonates associated with SSRIs.
As of now, epidemiological data reported about two in 100 neonates are being born with heart defects. However, maternal use of SSRIs may raise the risk of such complications by four in 100 neonates, Dr. Stephen concluded.
Find us on facebook